The company is a leading developer and contract manufacturer of pharmaceuticals for the global cellular therapies industry. Cognate offers a range of custom services to companies engaged in the development and manufacture of cell-based products, from early preclinical studies to commercial manufacturing. With a highly experienced staff and cGMP facilities, Cognate is one of the most qualified contract manufacturers of cell-based products in the world. The company specializes in cell and cell-mediated gene therapies, and applies its expertise to successfully develop autologous and allogeneic products across multiple cell-based technology platforms.